Celgene Corp. to pay $280M to settle cancer drug fraud suit

Tuesday, July 25, 2017 - 18:02 in Mathematics & Economics

LOS ANGELES (AP) -- A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal lawsuit alleging it committed fraud by promoting a drug for leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net